Stockreport

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

TNF Pharmaceuticals, Inc.  (TNFA) 
PDF Prevail Partners, LLC investment priced at more than a 40% premium to marketPrevail InfoWorks, Inc. to act as Clinical Research Organization partner; global full service [Read more]